Antibiotic exposure and interpersonal variance mask the effect of ivacaftor on respiratory microbiota composition
G551D is a class III mutation of the cystic fibrosis transmembrane regulator (CFTR) that results in impaired chloride channel function in cystic fibrosis (CF). Ivacaftor, a CFTR-potentiating agent improves sweat chloride, weight, lung function, and pulmonary exacerbation rate in CF patients with G551D mutations, but its effect on the airway microbiome remains poorly characterised.
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Anton Y. Peleg, Jocelyn Choo, Katherine Langan, Deirdre Edgeworth, Dominic Keating, John Wilson, Geraint B. Rogers, Tom Kotsimbos Tags: Original Article Source Type: research